SOURCE: AVX Corporation

AVX Corporation

April 18, 2017 09:30 ET

AVX Adds New Medical Device Development Facility to its Corporate Headquarters

With more than 2,500 square feet of cleanrooms & support space for device fabrication, biological analysis, & electrical testing, the new facility will further extend AVX's robust portfolio of components for Class I, II, & III medical devices

FOUNTAIN INN, SC--(Marketwired - April 18, 2017) - AVX Corporation (NYSE: AVX), a leading manufacturer and supplier of passive components and interconnect solutions, has added a new medical device development facility to its corporate headquarters in Fountain Inn, S.C. With more than 2,500 square feet of cleanrooms and support space for device fabrication, biological analysis, and electrical testing equipment, the new medical device development lab will accommodate the efforts of eight to ten researchers dedicated to developing cutting-edge medical components. These devices will further extend AVX's robust portfolio of passive and interconnect solutions especially designed to satisfy the stringent electrical and mechanical performance demands of Class I, II, and III medical devices.

"Backed by more than 20 years' experience providing advanced passive component and interconnect solutions to the medical industry, our new medical device development facility represents an investment of more than $2.1 million and demonstrates our continued commitment to developing state-of-the-art component solutions for life-saving and life-enhancing technologies," said John Lawing, CTO and vice president of R&D, AVX. "Our medical design engineers have an innovative approach to problem solving and an in-depth understanding of medical device design requirements, and our quality systems lead the industry and support customer-specific change control, documentation, specification, and testing procedures."

AVX offers a wide range of advanced tantalum and ceramic capacitors, thin film products, connectors, EMI filters and feedthroughs, SAW filters, and timing devices for medical applications spanning Class III implantable and life-support devices, including: pacemakers, implantable cardioverter-defibrillators (ICDs), and neuromodulation devices, to Class I and II devices, including: cochlear implants, insulin pumps, drug pumps, hearing aids, heart monitors, vascular assist devices, MRI and X-ray machines, external defibrillators, and other monitoring and diagnostic devices.

For more information about AVX's robust portfolio of passive component and interconnect solutions for Class I, II, and III medical devices, please visit the Medical Industry Applications page at http://www.avx.com/industry-applications/medical/ or email medical.info@avx.com. For more information about AVX's current component solutions for Class II and Class III medical devices, please visit http://catalogs.avx.com/MedicalProducts.pdf to access their Medical Selector Guide. For all other inquiries, please visit www.avx.com, call 864-967-2150, or write to One AVX Boulevard, Fountain Inn, S.C. 29644.

About AVX
AVX Corporation is a leading international manufacturer and supplier of electronic passive components and interconnect solutions with 20 manufacturing and warehouse facilities in 11 countries around the world. AVX offers a broad range of devices including capacitors, resistors, filters, timing and circuit protection devices, and connectors. The company is publicly traded on the New York Stock Exchange (NYSE: AVX).

A member of the Kyocera Group since 1990, AVX is also the only company authorized to supply Kyocera's electronic devices to the Americas and Europe. Established in 1959 and based in Kyoto, Japan, Kyocera Corporation is a leading international supplier of connectors, capacitors, ceramic resonators, surface acoustic wave (SAW) filters and duplexers, and crystal oscillators and timing devices.

Image Available: http://www.marketwire.com/library/MwGo/2017/4/17/11G135994/Images/AVX186_New_Medical_Electronics_Lab_Facility_PR-74bd109316e1a8ee916cc1210278c49c.jpg

Contact Information